5-Methylpyrazine-2,3-dicarboxylic acid

Catalog No.: 
ACKJNF294
CAS No.: 
5521-60-8
Molecular Formula: 
C7H6N2O4
Molecular Weight: 
182.13
5-Methylpyrazine-2,3-dicarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$50.00In stockInquiry
250mg95%$84.00In stockInquiry
1g95%$211.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methylpyrazine-2,3-dicarboxylic acid
IUPAC Name5-methylpyrazine-2,3-dicarboxylic acid
MDL No.MFCD06200818
Molecular FormulaC7H6N2O4
Molecular Weight182.13
SMILESCC1=CN=C(C(O)=O)C(=N1)C(O)=O
InChI KeyZSVGGGCOTVOOSG-UHFFFAOYSA-N
SynonymRARECHEM AL BO 0807;5-methyl-2,3-pyrazinedicarboxylic acid;5-METHYLPYRAZINE-2,3-DICARBOXYLIC ACID;5-Methylyrazine-2,3-dicarboxylicacid;1-[4-(diethylamino)anilino]ethanesulfonic acid;2,3-Pyrazinedicarboxylic acid, 5-methyl-;sodium 5-methylpyrazine-2,3-dicarboxylate;Glipizide Impurity 41
CAS No.5521-60-8
PubChem CID72668

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKJNF294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKJNF294 route product structure diagram
    ACKJNF2945521-60-8In Stock
Inquiry

2. ACKJNF294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKJNF294 route product structure diagram
    ACKJNF2945521-60-8In Stock
Inquiry

3. ACKJNF294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKJNF294 route product structure diagram
    ACKJNF2945521-60-8In Stock
Inquiry

Comments (0)